Title of article :
Molecular Identification and Antifungal Susceptibility Patterns of Candida Species Isolated from Candidemia Patients in Yasuj, Southwestern Iran
Author/Authors :
Rostami Yasuj ، Shaghayegh Cellular and Molecular Research Center - Yasuj University of Medical Sciences , Gharaghani ، Maral Department of Medical Mycology - School of Medicine - Ahvaz Jundishapur University of Medical Sciences , Khoramrooz ، Sajjad Cellular and Molecular Research Center - Yasuj University of Medical Sciences , Salahi ، Marjan Cellular and Molecular Research Center - Yasuj University of Medical Sciences , Keshtkari ، Ali Department of Pediatrics - School of Medicine - Yasuj University of Medical Sciences , Taghavi ، Jabar Cellular and Molecular Research Center - Yasuj University of Medical Sciences , Nazari ، Khadigeh Student Research Committee - Yasuj University of Medical Sciences , Ansari ، Saham Department of Parasitology and Mycology - School of Medicine - Shahid Beheshti University of Medical Sciences , Shokoohi ، Gholamreza Department of Medical Parasitology and Mycology - School of Medicine, Zoonosis Research Center - Jahrom University of Medical Sciences , Nouripour-Sisakht ، Sadegh Medicinal Plants Research Center - Yasuj University of Medical Sciences
From page :
1
To page :
6
Abstract :
Background: Candidemia is the most common systemic infection in hospitalized patients causing high mortality. Hence, the diagnosis of this infection in the early stage with appropriate antifungal therapy is paramount. Objectives: The study aimed at molecular identification of Candida species isolated from candidemia patients and evaluation of the in vitro antifungal susceptibility patterns of these strains to fluconazole, amphotericin B, and caspofungin. Methods: In the present study, 800 hospitalized patients who were suspected to have candidemia were sampled. Candida species were isolated and identified based on morphological characteristics and PCR-sequencing of the ITS1-5.8S-ITS2 region. Antifungal susceptibility tests for fluconazole, amphotericin B, and caspofungin were performed according to the Clinical and Laboratory Standards Institute protocol M27-A3. Also, clinical data were recorded from the patients’ records. Results: Twenty-seven patients among the sample of hospitalized patients were found to have candidemia. A total of 33.3% of candidemia patients were treated with amphotericin B, in which case the mortality rate was 14.8%. The majority of patients (59%) were from the neonatal intensive care unit, and premature birth was the most common underlying condition. Candida albicans (n = 18; 66.6%) was the most common species isolated from blood cultures, followed by C. parapsilosis (n = 7; 25.9%), C. pelliculosa (n = 1; 3.7%), and C. tropicalis (n = 1; 3.7%). Only one C. albicans isolate resistant to fluconazole (minimum inhibitory concentration = 32 μg/mL). Conclusions: Generally, C. albicans has been the most frequent causative agent of candidemia. Resistance to antifungal drugs among candidemia agents was rare. Also, the identification of Candida isolates at the species level with in vitro antifungal susceptibility tests helps manage candidemia patients better and decrease the mortality rate among them.
Keywords :
Candidemia , Candida albicans , Antifungal Susceptibility , Antifungals
Journal title :
Jundishapur Journal of Microbiology (JJM)
Journal title :
Jundishapur Journal of Microbiology (JJM)
Record number :
2683731
Link To Document :
بازگشت